Your browser doesn't support javascript.
loading
[Contribution of RT-PCR for diagnosis of chronic myeloid leukemia]
Archives de l'Institut Pasteur de Tunis. 2006; 83 (1-4): 35-39
Dans Français | IMEMR | ID: emr-76077
ABSTRACT
The molecular analysis of chromosomal abnormalities associated with hematological malignancies allowed the identification of genes involved in theses rearrangements as well as of some recurrent mechanisms. Polymerase chain reaction [PCR] tools are now available to detect these rearrangements, allowing a better follow-up of these diseases. Chronic myeloid leukemia is a myeloproliferative disorder characterized by a reciprocal translocation t[9;22][q34;q11] which results in a bcr-abl fusion gene. Retro-transcription polymerase chain reaction [RT-PCR] is used to detect bcr-abl to establish diagnosis and to monitor patients. We report here the results of 30 patients samples tested in the hematology laboratory at Pasteur Institute, diagnosed as chronic myeloid leukemia and monitored with RT-PCR. Our results highlight the interest of molecular tools to diagnose and monitor patients mainly when cytogenetic techniques are irrelevant such as cases with complex chromosomal rearrangements or when patients achieve Philadelphia negativity after treatment
Sujets)
Recherche sur Google
Indice: Méditerranée orientale Sujet Principal: Chromosome Philadelphie / Leucémie myéloïde chronique BCR-ABL positive / Gènes abl / RT-PCR Limites du sujet: Femelle / Humains / Mâle langue: Français Texte intégral: Arch. Inst. Pasteur Tunis Année: 2006

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Recherche sur Google
Indice: Méditerranée orientale Sujet Principal: Chromosome Philadelphie / Leucémie myéloïde chronique BCR-ABL positive / Gènes abl / RT-PCR Limites du sujet: Femelle / Humains / Mâle langue: Français Texte intégral: Arch. Inst. Pasteur Tunis Année: 2006